Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-6
Publisher
Informa UK Limited
Online
2020-08-27
DOI
10.1080/21645515.2020.1796425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
- (2020) Syed Faraz Ahmed et al. Viruses-Basel
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine
- (2020) Lynne Peeples PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
- (2020) Kuldeep Dhama et al. Human Vaccines & Immunotherapeutics
- COVID-19: an Immunopathological View
- (2020) Kamran Kadkhoda mSphere
- Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
- (2020) Ruklanthi de Alwis et al. EBioMedicine
- Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures
- (2020) Nikolai Eroshenko et al. NATURE BIOTECHNOLOGY
- Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
- (2020) Huibin Lv et al. Cell Reports
- Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
- (2020) Eriko Padron-Regalado Infectious Diseases and Therapy
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
- (2019) Alexandra C. Walls et al. CELL
- Immunological Lessons from Respiratory Syncytial Virus Vaccine Development
- (2019) Tracy J. Ruckwardt et al. IMMUNITY
- Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
- (2019) Chean Yeah Yong et al. Frontiers in Microbiology
- Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection
- (2018) Rekha Khandia et al. Frontiers in Immunology
- Viral-Induced Enhanced Disease Illness
- (2018) Maria K. Smatti et al. Frontiers in Microbiology
- Application of camelid heavy-chain variable domains (VHHs) in prevention and treatment of bacterial and viral infections
- (2017) Lucas Wilken et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Antibody-dependent enhancement of severe dengue disease in humans
- (2017) Leah C. Katzelnick et al. SCIENCE
- Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
- (2017) Katherine V. Houser et al. PLoS Pathogens
- Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus
- (2017) Kittirat Glab-ampai et al. Scientific Reports
- Vaccines for the prevention against the threat of MERS-CoV
- (2016) Lanying Du et al. Expert Review of Vaccines
- Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
- (2016) David J. DiLillo et al. JOURNAL OF CLINICAL INVESTIGATION
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
- (2016) Lanying Du et al. Nature Communications
- Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
- (2016) Qidi Wang et al. ACS Infectious Diseases
- Fc receptors in antibody-dependent enhancement of viral infections
- (2015) Adam Taylor et al. IMMUNOLOGICAL REVIEWS
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- T Cell Responses to Whole SARS Coronavirus in Humans
- (2014) C. K.-f. Li et al. JOURNAL OF IMMUNOLOGY
- Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
- (2014) Fumihiko Yasui et al. VIROLOGY
- Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
- (2013) Sudhakar Agnihothram et al. JOURNAL OF INFECTIOUS DISEASES
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
- (2012) Chien-Te Tseng et al. PLoS One
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent Fc R Pathway
- (2011) M. Jaume et al. JOURNAL OF VIROLOGY
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
- (2008) Theodore C. Pierson et al. Cell Host & Microbe
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now